Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
Reviva Pharmaceuticals Holdings, Inc. (RVPH)
Company Research
Source: Yahoo! Finance
- Current data package highlights well-tolerated long-term safety profile, broad-spectrum clinical activity, and favorable adherence for once daily brilaroxazine up to one year - - Initiation of RECOVER-2 registrational trial planned in mid-2026 - CUPERTINO, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today reported financial results for the full year ended December 31, 2025 and summarized recent business highlights. “With clear and actionable guidance from the Food and Drug Administration (FDA), we are advancing toward initiating our second registrational phase 3 trial (RECOVER-2) and preparing the data package for supporting a New Drug Application (NDA) for brilaroxazine for the treatment of schizophrenia,” said
Show less
Read more
Impact Snapshot
Event Time:
RVPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVPH alerts
High impacting Reviva Pharmaceuticals Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
RVPH
News
- Reviva Reports Full Year 2025 Financial Results and Recent Business HighlightsGlobeNewswire
- Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public OfferingGlobeNewswire
- Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public OfferingGlobeNewswire
- Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public OfferingGlobeNewswire
RVPH
Earnings
- 3/30/26 - Miss
RVPH
Sec Filings
- 3/30/26 - Form SCHEDULE
- 3/30/26 - Form S-8
- 3/30/26 - Form 8-K
- RVPH's page on the SEC website